Logo
Login
$TCRT
$2.13 -$0.15 (6.58%) Close

Ownership

13F as of Q2 2026 · 2.5M shares outstanding

Who owns TCRT?

By type of holder
Institutions 3.6% Insiders 44.9% Everyone else 51.5%
Concentration Top 10 holders own 176.7%
Fairmount Funds Management LLC 33.8% · Fairmount Healthcare Co-Invest VII L.P. 33.8%
Institutional ownership
3.6%
-1.4 pts vs last qtr
Institutional holders
29
0 vs last qtr
Net shares bought
−35.6K
by institutions in Q2 2026
New / sold out
6 / 6
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Citadel Advisors LLC +1.4K
  • Arax Advisory Partners NEW +1.2K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • HRT Financial LP SOLD OUT −13.3K
  • Two Sigma Investments, LP SOLD OUT −10.8K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Alaunos Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+124.1%
+9.38% a year
Each share's claim on the business
−55.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$2.32M vs $55.9M
over 10 fiscal years
Diluted shares, split-adjusted
843.2K1.4M2.0M2016: 869.3K shares'162017: 912.9K shares'172018: 958.1K shares'182019: 1.1M shares'192020: 1.4M shares'202021: 1.4M shares'212022: 1.4M shares'222023: 1.6M shares'232024: 1.6M shares'242025: 1.9M shares'25
Buybacks Stock-based comp
$0$5.4M$10.8M2016 buybacks: $2.0K2016 stock comp: $8.5M'162017 buybacks: $02017 stock comp: $8.5M'172018 buybacks: $1.6M2018 stock comp: $7.5M'182019 buybacks: $653.0K2019 stock comp: $6.3M'192020 buybacks: $02020 stock comp: $6.8M'202021 buybacks: $02021 stock comp: $10.8M'212022 buybacks: $45.0K2022 stock comp: $3.5M'222023 buybacks: $02023 stock comp: $2.8M'232024 buybacks: $02024 stock comp: $435.0K'242025 buybacks: $02025 stock comp: $796.0K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years85% Under 1 year15%
Quarterly turnover
16.8%
of institutional shares changed hands
Top 10 managers, median time held
1.8 years

Super Investors

Investment managers reporting TCRT on Form 13F
GC
Geode Capital Management, LLC
Shares
19.4K
% of company
0.76%
Change vs last qtr
−3.2K (−14.2%)
Held since
2024
B
BlackRock, Inc.
Shares
21.4K
% of company
0.84%
Change vs last qtr
Unchanged
Held since
2024

28 more super investors behind a free account

See every manager holding Alaunos Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting TCRT on Form N-PORT; together they hold 1.3% of the company
VE
Vanguard Extended Market Index Fund
Vanguard Index Funds
Position value
$31.8K
% of company
0.55%
% of the fund
0.00%
As of
June 30, 2026
FE
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
Position value
$20.6K
% of company
0.48%
% of the fund
0.00%
As of
August 31, 2026

3 more funds behind a free account

See every fund holding Alaunos Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FF
Fairmount Funds Management LLC
5%+ holder13D · 20.0%
Shares
858.8K
% of company
33.80%
Change vs last qtr
—
Held since
—
FH
Fairmount Healthcare Co-Invest VII L.P.
5%+ holder13D · 20.0%
Shares
858.8K
% of company
33.80%
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of Alaunos Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans